Jonathan Aschoff Analyst PerformanceAnalyst at Roth CapitalJonathan Aschoff is a stock analyst at Roth Capital focused in the medical sector, covering 22 publicly traded companies. Over the past year, Jonathan Aschoff has issued 2 stock ratings, including and buy recommendations. While full access to Jonathan Aschoff's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jonathan Aschoff's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings134 Last 12 YearsBuy Recommendations91.73% 122 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution133RatingsDistribution of strong buy, buy, hold, and sell ratings by Jonathan Aschoff.RatingPercentageCount Strong Buy0.0%0 ratings Buy91.7%122 ratings Hold4.5%6 ratings Sell3.8%5 ratingsOut of 133 total stock ratings issued by Jonathan Aschoff at Roth Capital, the majority (91.7%) have been Buy recommendations, followed by 4.5% Hold and 3.8% Sell.Best & Worst CallsBest Call0000.0%CURJan 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CMRXAug 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ90.9% of companies on NASDAQ20 companiesNYSEAMERICAN4.5% of companies on NYSEAMERICAN1 companyOTCMKTS4.5% of companies on OTCMKTS1 companyJonathan Aschoff, an analyst at Roth Capital, currently covers 22 companies listed on NASDAQ, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical21 companies95.5%Manufacturing1 company4.5%Jonathan Aschoff of Roth Capital specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE10 companies45.5%MED - DRUGS4 companies18.2%PHARMACEUTICAL PREPARATIONS4 companies18.2%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES1 company4.5%MED - OUTP/HM CRE1 company4.5%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company4.5%MED PRODUCTS1 company4.5% About Jonathan Aschoff Jonathan Aschoff, Ph.D., is a Managing Director, Senior Research Analyst at ROTH, specializing in the biotechnology sector. With over 20 years of experience as a sell-side analyst, he has focused primarily on small and microcap companies within the biotechnology industry. Throughout his career, he has earned several awards in the biotechnology or pharmaceutical sector based on investment return, including recognition from organizations such as The Wall Street Journal, Financial Times, Forbes, Starmine, and Tipranks. Dr. Aschoff earned a B.S. in Biology and a Ph.D. in Microbiology and Molecular Biology from Tufts University. During his Ph.D. studies at Tufts University School of Medicine, his research involved investigating the function of the 3' untranslated avian retroviral genomic mRNA region.Follow on LinkedIn Jonathan Aschoff's Ratings History at Roth Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsNVCTNuvectis Pharma7/6/2026Boost Price Target$19.57$33.00Buy$0.0000.00% ROIPTHSPelthos Therapeutics2/26/2026Lower Price Target$23.00$55.00Buy$0.0000.00% ROIOTRKOntrak7/9/2025Lower Price Target$0.42$3.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysMorgan StanleyRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftRaymond James FinancialStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
